The Global Mechanical Ventilators Market is valued at USD 5.39 Billion in 2024 and is expected to reach USD 7.96 Billion by 2030 with a CAGR of 6.7% over the forecast period. Amplifying prevalence of chronic obstructive pulmonary disease (COPD) and growing geriatric population are boosting the demand for mechanical ventilators across the globe.
Mechanical ventilation is also recognized as intermittent mandatory ventilation (IMV). These are medical terms that work as ventilators by using machines to fully or, to some extent, provide unnatural ventilation. The special purpose of these ventilators is to help patients deliver oxygen and remove carbon dioxide. There are different pros to using mechanical ventilators, like guarding the airway due to mechanical or neurologic causes, removing additional carbon dioxide from the lungs, or ensuring sufficient oxygenation. Thus, various healthcare sources are willing to use mechanical ventilation, and people who use ventilators are typically monitored in a serious care unit. The life-saving therapy that was either negative or positive-pressure ventilation appeared in the early 1800s by Andreas Vesalius.
The overall impact of the COVID-19 outbreak has been positive on the mechanical ventilator market. The COVID-19 pandemic presents a mirror in front of the regulatory community, life sciences industry, and healthcare system, which can respond to a global outbreak of a highly communicable and deadly disease. In fact, in many countries, the demand for applicable medical devices and equipment quickly overtakes supply, leading to critical shortages, particularly the increasing demand for ventilators and personal protective equipment (PPE). Thus, traditional, and new medical equipment manufacturers have hinged many of their activities on meeting this demand. At the same time, both international and national regulatory bodies have been required to adapt their methods for granting market approval. For instance, the FDA issued Emergency Use Authorization (EUA) letters, expediting the commercialization of ventilators, PPE, and test kits through various channels.
The global mechanical ventilator market is segmented based on product, component, mode, age group, end user, and region. Based on product type, the mechanical ventilator market is segmented into intensive care unit/critical care, transport/portable/ambulatory, and neonatal care. Based on components, the mechanical ventilator market is segmented into devices and services. Based on mode, the mechanical ventilator market is segmented into noninvasive ventilation and invasive ventilation. Based on age group, the mechanical ventilator market is segmented into pediatric and neonatal, adult, and geriatric. Based on end users, the mechanical ventilator market is segmented into hospitals and clinics, home care, and ambulatory surgical centers.
The regions covered in these mechanical ventilators markets are North America, Europe, Asia-Pacific, Latin, and the Middle East. Based on a country level, the mechanical ventilators market is subdivided into the U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Some of the key players for mechanical ventilators are Air Liquide Medical Systems, Airon Corporation, Allied Healthcare Products, Inc., BPL Medical Technologies, Draegerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Flight Medical Innovations, GE Healthcare, Getinge Group, Hamilton Medical AG, Maquet, Medtronic plc, Mindray Medical International Limited, Penlon Ltd., Philips Healthcare, ResMed Inc., Schiller AG, Smiths Group plc, Vyaire, Medical, ZOLL Medical Corporation, and Others etc.
11th September 2023 - A recently designed mechanical ventilator, initially conceived as an emergency response during the pandemic, now serves as a cost-effective and highly efficient alternative to help alleviate the worldwide shortage of these devices. This breakthrough technology not only meets the critical demand for ventilators in healthcare facilities across the globe but also does so at a fraction of the cost compared to traditional models.
September 8, 2023 - NovaVent is an innovative solution designed to provide continuous mandatory ventilation for individuals who lack the ability to breathe independently. Mechanical engineering professors at Villanova University in the United States have secured a patent for the creation of NovaVent, a cost-effective and groundbreaking mechanical ventilator.
The increasing prevalence of respiratory disorders is driving the growth of the mechanical ventilator market. The primary drivers of this market's growth are the rising prevalence of chronic obstructive pulmonary disease (COPD) and several respiratory disorders such as sleep apnea, critical lung injury, and hypoxemia. For COPD patients, this mechanical ventilator therapy has proven to be a lifesaving therapy. The mass of patients with acute respiratory failure due to acute aggravations of COPD (AECOPD) should undergo a trial of non-invasive mechanical ventilation (NIV), because cannulation can be successfully prevented, and death reduced with this intervention.
For instance, between 88% and 92% of the oxygen level is deemed safe for someone with normal to severe COPD in 2021. But in some cases, if this level falls, then it creates a hazard for those patients; that’s why they need ventilation from a mechanical ventilator. Thus, an increase in demand for mechanical ventilators pushes market growth.
The market is anticipated to experience increased growth due to the rising incidence of preterm births and the rapidly expanding geriatric demographic. In general, for preterm new-born babies, the first two to three breaths require more pressure for the first two to three breaths than subsequent breaths, which means initial lung inflation. Suggested ventilation rates for newborns during recovery are 40 to 60 breaths per minute in 2022. Habitually, 100% oxygen has been used for aided ventilation during new-born artificial respiration. Furthermore, the high occurrence of tobacco smoking, which affects respiratory disease, will drive market progress.
However, high costs for treatment, low awareness, and the risk of infection from germs entering the artificial airway are affecting the growth of the mechanical ventilator market. Furthermore, increasing awareness about ventilation by mechanical ventilators, an increase in investment by key players, and government funding for the development of mechanical ventilators are increasing the demand for mechanical ventilators.
Geographically, North America accounts for the leading share in the mechanical ventilators market. According to research, to increase market production in this region, some responsible driving factors are, increasing prevalence of chronic diseases, occurrence of key players for manufacturing & development of market size, surge in number of hospitals & diagnostic centres and initiatives taken by government. In addition, increase in aged respiratory disorders is one of the key handlers of the market.
For instance, according to the American Cancer Society’s 2021 facts, nearly all the people over the age of 65 are predisposed to lung cancer. There is another example for U.S. market for the mechanical ventilator is, in 2020, the FDA's EUA authority approved Medtronic permission to use PB560 in the US. In the past, the company sent out about 300 ventilators for each week. To battle the outbreak, it planned to increase production from 300 to 700 ventilators weekly. Thus, the market for mechanical ventilator is expanding.
Asia Pacific is second dominating region for mechanical ventilators market. Asia Pacific has remarkable growth in the mechanical ventilators market across the region. In Asia, increase in prevalence of chronic obstructive pulmonary disease (COPD), rising government expenditure in healthcare facilities, rising infectious and fatal disease prevalence, fast urbanization and rising respiratory disease prevalence, etc. factors are driving the market. During COVID-19 increasing demand for mechanical ventilators boosted the market value for mechanical ventilators. For better knowing, between 3 and 7% of people sick with the virus demand mechanical ventilation systems.
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®